Hypofractionated Stereotactic Body Radiotherapy in Low Risk Prostate Adenocarcinoma: Preliminary Results of a Multi-Institutional Phase I Feasibility Trial

被引：0
|
作者：
McBride, S. [1 ]
Wong, D. [2 ]
Dombrowski, J. J. [3 ]
Harkins, B. [2 ]
Tapella, P. [3 ]
Hanscom, H. [4 ]
Collins, S. P. [4 ]
Kaplan, I. D. [5 ]
机构：
[1] Harvard Radiat Oncol Program, Boston, MA USA
[2] Calif Canc Ctr, Fresno, CA USA
[3] St Louis Univ, Ctr Canc, St Louis, MO 63103 USA
[4] Georgetown Univ, Med Ctr, Washington, DC 20007 USA
[5] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2011年 / 81卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2011.06.680
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S417 / S417
页数：1
相关论文
共 50 条
  • [1] Hypofractionated stereotactic body radiotherapy in low-risk prostate adenocarcinoma
    McBride, Sean M.
    Wong, Douglas S.
    Dombrowski, John J.
    Harkins, Bonnie
    Tapella, Patricia
    Hanscom, Heather N.
    Collins, Sean P.
    Kaplan, Irving D.
    [J]. CANCER, 2012, 118 (15) : 3681 - 3690
  • [2] , HYPOFRACTIONATED RADIOTHERAPY FOR LOW RISK PROSTATE CANCER: PRELIMINARY RESULTS OF A PHASE I/II TRIAL
    Menkarios, C.
    Nguyen, D. H. A.
    Vigneault, E.
    Brochet, N.
    Bahary, J. P.
    Jolicoeur, M.
    Nguyen, T. Van
    Beauchemin, M. C.
    Fortin, B.
    Fortin, M. A.
    Lambert, C.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2009, 92 : S42 - S42
  • [3] Hypofractionated Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer: A Multi-institutional Phase 2 Analysis
    Gill, B. S.
    Olsheski, M. E.
    DAmbrosio, D. J.
    Clump, D. A., II
    Wegner, R. E.
    Iyer, R.
    Burton, S. A.
    Holeva, K.
    Heron, D. E.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E197 - E198
  • [4] Stereotactic body radiation therapy for low and intermediate risk prostate cancer-Results from a multi-institutional clinical trial
    Hannan, Raquibul
    Tumati, Vasu
    Xie, Xian-Jin
    Cho, L. Chinsoo
    Kavanagh, Brian D.
    Brindle, Jeffrey
    Raben, David
    Nanda, Akash
    Cooley, Susan
    Kim, D. W. Nathan
    Pistenmaa, David
    Lotan, Yair
    Timmerman, Robert
    [J]. EUROPEAN JOURNAL OF CANCER, 2016, 59 : 142 - 151
  • [5] A Multi-Institutional Prospective Phase II Trial of Hypofractionated Stereotactic Body Radiotherapy (SBRT) in the Treatment of Metastatic Pediatric Sarcomas of Bone Sites
    Elledge, C. R.
    Krasin, M.
    Han, P.
    Alcorn, S. R.
    Hiniker, S. M.
    Gibbs, I. C.
    Ladra, M.
    Laack, N. N., II
    Terezakis, S. A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S186 - S186
  • [6] Phase 2 Multi-institutional Trial Evaluating Gemcitabine and Stereotactic Body Radiotherapy for Patients With Locally Advanced Unresectable Pancreatic Adenocarcinoma
    Herman, Joseph M.
    Chang, Daniel T.
    Goodman, Karyn A.
    Dholakia, Avani S.
    Raman, Siva P.
    Hacker-Prietz, Amy
    Iacobuzio-Donahue, Christine A.
    Griffith, Mary E.
    Pawlik, Timothy M.
    Pai, Jonathan S.
    O'Reilly, Eileen
    Fisher, George A.
    Wild, Aaron T.
    Rosati, Lauren M.
    Zheng, Lei
    Wolfgang, Christopher L.
    Laheru, Daniel A.
    Columbo, Laurie A.
    Sugar, Elizabeth A.
    Koong, Albert C.
    [J]. CANCER, 2015, 121 (07) : 1128 - 1137
  • [7] Long-term outcomes of stereotactic body radiotherapy for low- and intermediate-risk prostate adenocarcinoma: A multi-institutional consortium study.
    Kishan, Amar Upadhyaya
    Katz, Alan J.
    Mantz, Constantine
    Chu, Fang-, I
    Appelbaum, Limor
    Loblaw, Andrew
    Cheung, Patrick
    Kaplan, Irving D.
    Fuller, Donald B.
    Pham, Huong T.
    Meier, Robert
    Buyyounouski, Mark K.
    Shaverdian, Narek
    Dang, Audrey
    Yuan, Ye
    Bagshaw, Hilary
    Prionas, Nicolas
    Kupelian, Patrick
    Steinberg, Michael L.
    King, Christopher R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [8] Stereotactic Body Radiotherapy for High-Risk Prostate Cancer: Preliminary Toxicity Results of a Phase 2 Trial
    Kishan, A. U.
    Fuller, D. B.
    Steinberg, M. L.
    Ramirez, V.
    Ostendorf, E.
    Tsai, S. H.
    Agazaryan, N.
    Ruan, D.
    Cao, M.
    Kupelian, P. A.
    King, C. R.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E248 - E248
  • [9] Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Lung Metastases
    Rusthoven, Kyle E.
    Kavanagh, Brian D.
    Burri, Stuart H.
    Chen, Changhu
    Cardenes, Higinia
    Chidel, Mark A.
    Pugh, Thomas J.
    Kane, Madeleine
    Gaspar, Laurie E.
    Schefter, Tracey E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (10) : 1579 - 1584
  • [10] Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Liver Metastases
    Rusthoven, Kyle E.
    Kavanagh, Brian D.
    Cardenes, Higinia
    Stieber, Volker W.
    Burri, Stuart H.
    Feigenberg, Steven J.
    Chidel, Mark A.
    Pugh, Thomas J.
    Franklin, Wilbur
    Kane, Madeleine
    Gaspar, Laurie E.
    Schefter, Tracey E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (10) : 1572 - 1578
12345